Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
Gregory A. Curt(National Cancer Institute), Nicholas J. Vogelzang(Comprehensive Cancer Centers of Nevada), William Breitbart(Memorial Sloan Kettering Cancer Center), Loretta M. Itri(National Institutes of Health), Sandra J. Horning(Stanford University), Susan L. Scherr(National Coalition for Cancer Survivorship), Christine Miaskowski(Office of the Director), Russell K. Portenoy(Albert Einstein College of Medicine), David H. Johnson(Texas A&M University), Jerome E. Groopman(Harvard University), David Cella(Northwestern University)
Cited by 1,250
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k